scholarly journals The Effect of COVID-19 on Hospitalized Cancer Patients and Their Healthcare

Author(s):  
Jahnvi Garg ◽  
Ranjit S. Ambad ◽  
Nandkishor Bankar

Introduction: This article includes the effect of Corona virus disease on cancer patients and their healthcare facilities. The global pandemic mentioned around the world has impacted the most vulnerable group of patients- cancer. With the assistance of RT PCR tests and HRCT, oncologists and doctors have tried to provide treatment to Covid-19 patients. Cancer patients are more susceptible to Covid-19 than non-cancer or non-survivor patients, according to reports. To avoid the prevalence and infection of cancer victims, WHO has suggested staying at home and continuing their treatment through telemedicine unless the situation is critical for which they might require therapy and/or surgery. Covid-19 is here to stay so we should practice with utmost care and precaution.

Author(s):  
Sarfaraz Alam Khan ◽  
Nazeem Ishrat Siddiqui

A series of acute and atypical serious respiratory illnesses were reported in December 2019 from Wuhan, a city of China. It spread to other places and became a global pandemic involving more than 200 countries of the world. Soon, it was discovered that this atypical respiratory illness was caused by a novel corona virus. It was named as the severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) and the disease caused by it as corona virus disease-19 (COVID-19). Since COVID-19 is a new viral disease, world is still struggling to find out a permanent remedy to control this serious health problem. It seems prudent to study or have a look on the pathophysiology of SARS CoV-2 in the light of available research. Further, a review on pathophysiology may give an insight on the potential therapeutic options. Being a new virus and having potential to cause significant morbidity and mortality in short span of time various approved drugs are being repurposed for the treatment of COVID-19.


Author(s):  
R. Vennila ◽  
R. Vennila ◽  
P. Venkatraman

In 21st century, the year 2020 was expected with much development in India as well many other countries. But unfortunately, the world is facing many natural calamities. World is taking steps towards rescue mission of the disasters. Among of those calamities, deadly Corona Virus remains still all over the world as pandemic disease. Even the developed countries are struggling to come back to its normal routine. India is a country with developing technologies. Vaccines are yet to be developed for treatment of this Novel Corona Virus. As a diagnostic tool, Nasopharyngeal and Oropharyngeal swabs are taken from the person and tested using RT-PCR. This test is not 100 percent accurate. Confirmed COVID patients after few days are undergoing the medical imaging. This diagnostic imaging technique helps in showing the progression of this virus spread in Upper and Lower respiratory system. Chest Radiography is low cost modality but its sensitivity towards observation is 69%. Lung Ultrasound is used in Intensive Care patients and not used for routine diagnosing purpose. Computed Tomography plays a crucial role in three-dimensional chest imaging of COVID-19 patients. The sensitivity of CT is 98%. The aim of this paper is to consider CT as a tool for diagnosing COVID-19 patient than using the standard tool RT-PCR. A brief knowledge about imaging modality like X-ray, Ultrasound and Computed Tomography when used against COVID patient is explained. This paper gives reason for the ideal use of CT diagnosis for COVID 19.


2021 ◽  
Vol 7 (1) ◽  
pp. 19-24
Author(s):  
Zahid Habib ◽  
◽  
Misbah ul Haque ◽  
Yawer Hafeez ◽  
Maysaa M Ashkanani ◽  
...  

Background: There is a global spread of Corona Virus Disease (COVID-19) with Severe Acute Respiratory Syndrome Corona Virus-2 (SARS-CoV-2) being identified as the causative organism. This pandemic has infected over 53 million people globally causing over 1.3 million deaths resulting in lockdowns being implemented across many countries in the world. Global travel has been severely restricted especially in the early phase with far reaching social, economic and emotional implications. In addition to local measures undertaken by each country to curtail the spread of the disease, many countries implemented entry restriction on flights to reduce the risk of importing the disease by potentially infected incoming travellers. The State of Qatar eased travel restrictions from 1st of September 2020 (Phase IV of reopening of pandemic restrictions) [1]. Incoming travellers from high risk countries had to have a mandatory COVID-19 Naso-Oropharyngeal swab negative result before boarding their flight to Qatar. Then they had to commit to two weeks of compulsory quarantine. Travellers from low risk countries had to be swabbed at Hamad international airport on arrival, followed by a week’s mandatory home quarantine. All travellers had to have COVID-19 RT-PCR nasooropharyngeal swab on day 6 after arrival in Qatar. Method: We looked at the data provided by Ministry of Public Health (MOPH), Qatar from 1st of September to 30th of November. This was retrospective observational study looking at the prevalence of COVID positivity of return travellers as compared to the total positive cases in the country [1]. Results: In our review, out of a total of 19,909 COVID-19 positive cases, 2692 were incoming travellers which amounts to about 14 % of total COVID positive cases in Qatar. It was also noted that with each passing day, the ratio of incoming traveller’s in comparison to the total cases have been increasing, with figures of 9% in September 2020 as compared to 21% in November 2020. Conclusion: This figure clearly shows how important it is to screen all return travellers for COVID-19 as travellers are generally asymptomatic and could potentially spread the disease in the local community. All countries should consider implementing similar policies to reduce the risks of importing COVID-19.


Author(s):  
Shahid Nawaz

: The emergence of severe acute respiratory syndrome (SARS) in Wuhan (china) named as corona virus disease 19(covid-19) caused by the novel corona virus SARS-CoV-2 has caused hundreds of thousands of mortalities across the world ,while the mortality rate is in millions, leading it to be declared as a global pandemic. Numerous research activities are undergoing to reveal the disease and etiological features of covid-19. In this review, some of the interesting aspects of covid-19 are discussed, that includes, the origin of the SARS-CoV-2, clinical manifestation, treatment and future aspects of the disease.


2021 ◽  
Vol 28 ◽  
pp. 107327482110443
Author(s):  
Raj H. Patel ◽  
Rachana Vanaparthy ◽  
John N. Greene

The global pandemic of the novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has presented newfound challenges to the oncology community regarding management of disease progression in immunocompromised and cancer patients. Further, the large influx of COVID-19 patients has overwhelmed healthcare facilities, limited access to intensive care unit beds and ventilators, and canceled elective surgeries causing disruptions to the cancer care continuum and re-organization of oncological care. While it is known that the potential threat of infection is greatest in elderly patients (>60 years of age) and patients with underlying comorbidities, there is still insufficient data to determine the risk of COVID-19 in cancer patients. Given the immunosuppressive status in cancer patients arising from chemotherapy and other comorbidities, management of COVID-19 in this patient population carries a unique set of challenges. We report three cases of COVID-19 in immunocompromised cancer patients and discuss the challenges in preventing, diagnosing, and treating this vulnerable group.


2021 ◽  
Vol 10 (1) ◽  
pp. 29-37
Author(s):  
Harsimran Singh ◽  
Santosh Kumar ◽  
Rakesh Kumar

COVID-19 is a global pandemic and life threatening virus that mainly influences the respiratory tract of mammals, consisting humans being. It was 1st isolated in 1937 from an infectious bronchitis virus in birds. Many years ago, scientists have investigated that corona virus can infect mice, horses, dogs, pigs, rats, cats, cattle and turkeys. This zoonotic virus was first identified from Wuhan City, China and presently increasing very rapidly. The world has confirmed 141,057,106 cases, which includes 3,015,043 deaths and 793,484,083 vaccine doses administered as per the WHO till 20th April, 2021. Hence the aim of this paper is to provide a detailed review of COVID-19 including their history, origin, characteristics, symptoms and impacts along with preventive measures to be taken to restrict the outbreak of this evil virus of on human life.


Author(s):  
Abhishek Uppula

Abstract: Corona virus disease 2019 (COVID 19) is defined as illness caused by novel corona virus now called severe acute respiratory syndrome corona virus 2 (SARS-Cov-2; formally called as 2019-nCov), which was first identified in Wuhan City, Hubei Province, China. The spreading of COVID 19 is very fast throughout the world. World economy as well as public health has been facing a devastating effect caused by COVID 19. Hence detecting COVID 19 is challenging task even we have multiple methods like RT-PCR, COVID kits. The RT-PCR may not available in all laboratory, even exists which take some time to process and get reports and COVID 19 test kits may not available in all places. So, the main intention of this paper is to detect COVID 19 with in low budget, less time and accurate results. We have trained deep transferred learning models like ResNet-50, ResNet-101 using COVID positive, Normal, Viral Pneumonia chest x-rays. ResNet-50, ResNet-101 is pre-trained deep learning neural network. ResNet-50 provides 98% of accuracy where ResNet-101 gives us 97% of accuracy. Keywords: COVID 19, Deep Learning, ResNet-50, Transferred Learning, Artificial Intelligence.


Author(s):  
Youssriah Yahia Sabri ◽  
Mohamed Mohsen Tolba Fawzi ◽  
Eman Zaki Nossair ◽  
Safaa Mohamed El-Mandooh ◽  
Amira Aly Hegazy ◽  
...  

Abstract Background Corona Virus Disease 2019 (COVID-19) outbreak was officially announced as a global pandemic by the WHO on March 11th 2020. Thorough understanding of CT imaging features of COVID-19 is essential for effective patient management; rationalizing the need for relevant research. The aim of this study was to analyze the chest CT findings of patients with real-time polymerase chain reaction (RT-PCR) proved COVID-19 admitted to four Egyptian hospitals. The recently published RSNA expert consensus statement on reporting COVID-19 chest CT findings was taken into consideration. Results Normal CT “negative for COVID-19” was reported in 26.1% of our RT-PCR proved COVID-19 cases. In descending order of prevalence, imaging findings of the positive CT studies (73.9%) included GGO (69%), consolidation (49.7%), crazy paving (15.4%), and peri-lobular fibrosis (40.6%). These showed a dominantly bilateral (68.2%), peripheral (72.4%), and patchy (64.7%) distribution. Remarkably, thymic hyperplasia was identified in 14.3% of studies. According to the RSNA consensus, CT findings were classified as typical in 68.9%, indeterminate in 3.6%, and atypical in 1.4% of the evaluated CT studies. Conclusion Although COVID-19 cannot be entirely excluded by chest CT, it can be distinguished in more than two-thirds of cases; making CT a widely available, non-invasive, and rapid diagnostic tool.


2021 ◽  
Author(s):  
desna rura sarapang

The emergence of a new virus in the global world at the end of 2019, namely Corona Virus Disease 2019, brought tremendous excitement to all inhabitants of the earth. The emergence of this virus brings tremendous concern and fear to the world because the spread of this virus is quite fast, even the most frightening is that the risk of death of people exposed to this virus is very large. Indonesia itself, cannot avoid the impact of this Covid-19 case. As a form of efforts to prevent and minimize transmission of the virus, the Indonesian government has issued a social distancing / physical distancing recommendation. This situation also causes the interaction between communities to be very limited. This situation seems to be able to eliminate hospitality among the community. This paper aims to emphasize the importance of maintaining the value of Christian hospitality in society amid the Covid-19 pandemic.


2021 ◽  
pp. 238-242
Author(s):  
Pradeep Kumar Radhakrishnan ◽  
Gayathri Ananyajyothi Ambat ◽  
Roshini Ambat ◽  
Syed Ilas Basha ◽  
Hema Prakash ◽  
...  

On March 11 2020 WHO declares corona viral disease as a global pandemic .COVID 19 pandemic has taken the world by storm and many countries like India is now experiencing a second surge due to mutant strains. Global health emergency has been precipitated by this corona virus disease caused by SARS CoV2.Acute and intermediate effects on cardiovascular system are becoming obvious with progression of time. SARS-CoV-2-related endothelial dysfunction results in an augmented risk for venous thromboembolism, systemic vasculitis, endothelial cell apoptosis, and inammation in various organs. Acute infections have troponin elevation more due to indirect cardiac damage though denite patterns of direct damage do exist. Intermediate evaluation in patients with resolved infections shows increased incidence of exercise induced arrhythmias and residual cardiovascular symptoms. The virus with its zoonotic origin based upon its genomic identity to bat derived SARS corona virus has a human to human transmission mode.ACE 2 receptors facilitate cellular entry and has been implicated in direct and indirect myocardial damage. Myocarditis, acute myocardial injury, arrhythmias and thromboembolism dominates the clinical picture. Role of imaging must be dened in relation to relevant clinical ndings. With arrival of vaccine and widespread vaccination global programs, we can look forward to understanding and managing long term complications of this disease. Prognostic implications of a resolved disease need to be evaluated by future studies.


Sign in / Sign up

Export Citation Format

Share Document